Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature
Ulceration is the most common complication of infantile hemangioma (IH). We reported two cases of ulcerated IH treated by new cream formulation of brimonidine 0.2%–timolol 0.5% (a combination of selective α-2-adrenergic agonist and nonselective β-blocker). In both cases, ulcerations were healed with...
Main Author: | Mishal Almebayadh |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-05-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2019.1603991 |
Similar Items
-
Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01) -
ORAL TOPICAL TIMOLOL MALEAT OR ORAL PROPRANOLOL TREATMENT FOR INFANTILE HEMANGIOMAS: CLINICAL ANALYSIS OF 403 PATIENTS
by: Terzi Özlem, et al.
Published: (2023-09-01) -
Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas
by: Shih-Jen Chang, et al.
Published: (2022-08-01) -
Infantile hemangiomas: An update on pathogenesis, associations, and management
by: Karina L Vivar, et al.
Published: (2018-01-01) -
Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
by: Hai Wei Wu, et al.
Published: (2017-06-01)